サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1212611

ホルモン補充療法（HRT）の世界市場 2023

Hormone Replacement Therapy (HRT)
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 276 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ホルモン補充療法（HRT）の世界市場 2023
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ホルモン補充療法（HRT）の世界市場は2030年に401億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に245億米ドルと推定されるホルモン補充療法（HRT）の世界市場は、2030年までに401億米ドルの改定規模に達し、分析期間2022-2030年に6.3%のCAGRで成長すると予測されています。本レポートで分析したセグメントの1つであるエストロゲンホルモン置換療法は、CAGR6.4%を記録し、分析期間終了時には219億米ドルに達すると予測されます。パンデミック後の回復を考慮し、ヒト成長ホルモン補充療法分野の成長は、今後8年間のCAGRを7.5%に修正しました。

米国市場は72億米ドル、中国はCAGR5.9%の成長を予測

米国のホルモン補充療法（HRT）市場は、2022年に72億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが5.9％となり、2030年には70億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ5.7％と5.2％の成長が予測されています。欧州では、ドイツがCAGR約4.8%で成長すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-6453

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Hormone Replacement Therapy (HRT) Market to Reach $40.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Hormone Replacement Therapy (HRT) estimated at US$24.5 Billion in the year 2022, is projected to reach a revised size of US$40.1 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2022-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is projected to record a 6.4% CAGR and reach US$21.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Human Growth Hormone Replacement Therapy segment is readjusted to a revised 7.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 5.9% CAGR

The Hormone Replacement Therapy (HRT) market in the U.S. is estimated at US$7.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 47 Featured):

  • Abbott Laboratories
  • Allergan Plc
  • Bayer AG
  • Novartis AG
  • Noven Pharmaceuticals Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • TherapeuticsMD Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • An Introduction to Menopause and Hormone Replacement Therapy
    • Recent Market Activity
    • The HRT Controversy - An Insight
    • Newer Studies Challenge WHI Findings and Re-establish Safety of HRT
    • Revised Recommendations of the NAMS and Endocrine Society
    • IMS Consensus Guidelines Paving Way for More Clarity of HRT
    • The Regional Divide
    • Increasing Number of Menopausal Women - A Major Market Driver
    • New Bioidentical Drugs Serve Unmet Market Needs
    • Generic Incursion in Hormone Replacement Therapy - List of Drugs With and Without Approved Generic Versions
    • Intense Competition Marks the Global HRT Market
    • The Premarin Saga
    • Estrace Cream Drives Revenue Gains in Allergan's HRT Portfolio
    • Hormone Replacement Therapy (HRT) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • Allergan Plc (Ireland)
    • Bayer AG (Germany)
    • Noven Pharmaceuticals, Inc. (USA)
    • Novartis AG(Switzerland)
    • Novo Nordisk A/S (Denmark)
    • Orion Pharma AB (Finland)
    • Pfizer, Inc. (USA)
    • TherapeuticsMD, Inc. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Unmet Needs in Combination Therapies for HRT drive Research for New Medicines
    • Topical Estrogens - More Safe and Effective
    • Transdermal HRT Products Present Exciting Opportunities
    • Phytoestrogens - The New Panacea for Menopausal Symptoms?
    • Diet Link to Menopause Symptoms Raises Interest
    • Impact of Soy and Other Phytoestrogens - A Reality Check
    • EstroG - A Successful Herbal Health Supplement in Alleviating Menopausal Symptoms
    • The Growing Buzz around Bioidentical Drugs
    • Bio-identical Hormones - A Natural and Safe Substitute to Synthetic HRT?
    • Pellet Therapy - A New Innovation Downsizes Conventional Issues with Bioidentical HRT
    • Direct-to-Consumer Advertising for HRT - A Mixed Bag
    • Estriol: The Next Generation Estrogen Therapy?
    • What Makes Estriol Work?
    • Topical Estriol - More Promising in Safety
    • Estriol - Used More Commonly Outside the US
    • Entry of Generics Threatens Market Growth Prospects
    • Are Non-Hormonal Therapies A Threat to HRT?
    • Earlier Failures Induce Lethargy in Non-Hormonal Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Estrogen Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Estrogen Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Human Growth Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Human Growth Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Testosterone Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Testosterone Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Thyroid Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Thyroid Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Male Hypogonadism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Male Hypogonadism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Growth Hormone Deficiency by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hypothyroidism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 27: World 18-Year Perspective for Hypothyroidism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Type of Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 30: World 18-Year Perspective for Other Type of Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 31: World Hormone Replacement Therapy (HRT) Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: USA 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: USA 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Canada 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Canada 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • JAPAN
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Japan 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Japan 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • CHINA
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: China 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: China 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • EUROPE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hormone Replacement Therapy (HRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • FRANCE
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: France 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: France 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • GERMANY
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Germany 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Germany 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Italy 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Italy 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: UK 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: UK 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Hormone Replacement Therapy (HRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Product - Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Rest of World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Product - Percentage Breakdown of Value Sales for Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy and Thyroid Hormone Replacement Therapy for the Years 2012, 2023 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Hormone Replacement Therapy (HRT) by Type of Disease - Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Rest of World 18-Year Perspective for Hormone Replacement Therapy (HRT) by Type of Disease - Percentage Breakdown of Value Sales for Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism and Other Type of Diseases for the Years 2012, 2023 & 2030

IV. COMPETITION